Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.
There has been rise in the incidence and prevalence of blood disorders such as hemophilia for the last few years. According to Centers for Disease Control & Prevention (CDC) in the U.S., around 400 newborn babies are estimated to have hemophilia every year. According to National Hemophilia Foundation of the U.S., around 400,000 people across the globe are estimated to be living with hemophilia. Another bleeding disorder called von Willebrand disease is estimated to have prevalence of 1% among general population. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools. This, in turn, is likely to fuel the global coagulometers market during the forecast period. Moreover, there is rising consumption of anti-coagulant drugs such as aspirin and heparin, coagulometers are used to monitor the treatment progress in those patients. This factor is likely to propel the coagulometers market from 2017 to 2025. However, high cost of these devices diverts potential users toward manual coagulation testing, which is projected to restrain the global coagulometers market during the forecast period.
The global coagulometers market can be segmented based on product type, technology, channel type, aesthetics, end-user, and region. In terms of product type, the market can be divided into automated and semi-automated coagulometers. Based on technology, the market can be divided into mechanical detection, photo-optical detection, electrochemical detection, and others. Most of the automated coagulometers work on the principle of photo-optical or electrochemical detection. This is estimated to result in a significant share held by these segments. The others segment includes combination of the above-mentioned technologies and other innovative methods. Based on channel type, the market can be segregated into single-channel, double-channel, and multichannel coagulometers. Multichannel coagulometers are widely used in diagnostic laboratories and hospitals, which is projected to result in a prominent share held by the multichannel coagulometers segment in the global coagulometers market.
Based on aesthetics, the global coagulometers market can be segmented into portable and bench-top models. Based on end-user, the market can be divided into hospitals & diagnostic laboratories, home care settings, and research institutes. The hospitals & diagnostic laboratories segment is projected to account for a major share of the global coagulometers market from 2017 to 2025.
Geographically, the global coagulometers market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to hold a major share of the global market during the forecast period, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global market during the forecast period, due to high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market in the region during the forecast period.
Major players operating in the global coagulometers market are HORIBA, Ltd., Abbott, Tridema Engineering S.r.L., Erba Group, ratiolab, Maccura Biotechnology Co., Ltd., Bioline Technologies, SYCOmed e.K., Siemens Healthcare GmbH, Zymed, F. Hoffmann-La Roche Ltd., and Rayto Life & Analytical Sciences Co., Ltd.